Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) tablets, for oral useEPIVIR (lamivudine) oral solutionInitial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
EPIVIR is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. Limitations of Use: •The dosage of this product is for HIV‑1 and not for HBV.
- generic_name
- lamivudine
- product_names
- lamivudine
- ndc
- 49702-203, 49702-203-18, 49702-204, 49702-204-13, 49702-205, 49702-205-48
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en